Venous thromboembolic prophylaxis after elective total hip arthroplasty

Clinical Orthopaedics and Related Research

Volumn 441, Issue , 2005, Pages 274-284

  Conduah, Augustine ^a   Lieberman, Jay R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANALGESIA; BLEEDING; CLINICAL TRIAL; COMPRESSION THERAPY; CONFERENCE PAPER; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; ELECTIVE SURGERY; EVIDENCE BASED MEDICINE; HEMATOMA; HOSPITALIZATION; HUMAN; PATHOGENESIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RELIABILITY; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM; EMBOLISM; HIP ARTHROPLASTY; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; STATISTICS; VEIN THROMBOSIS;

ARTHROPLASTY, REPLACEMENT, HIP; EMBOLISM; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VENOUS THROMBOSIS;

EID: 33644815702     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000192358.33093.43     Document Type: Conference Paper

References (102)

1. Albrechtsson U, Olsson CG: Thrombotic side-effects of lower-limb phlebography. Lancet 1:723-724, 1976.
2. Alexander G, Gustafson A, Wise G: Comparison of warfarin use in total knee replacement versus total hip replacement. Orthopedics 20:117-120, 1997.
3. Allenby F, Boardman L, Pflug JJ, Calnan JS: Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet 2:1412-1414, 1973.
4. Arcelus JI, Caprini JA, Traverso CI: Venous thromboembolism after hospital discharge. Semin Thromb Hemost 19(Suppl 1):142-146, 1993.
5. Bailey JP, Kruger MP, Solano FX, Zajko AB, Rubash HE: Prospective randomized trial of sequential compression devices versus low-dose warfarin for deep venous thrombosis prophylaxis in total hip arthroplasty. J Arthroplasty 6(Suppl):S29-S35, 1991.
6. Barrack RL, Sawhney J, Hsu J, Cofield RH: Cost analysis of revision total hip arthroplasty: A 5-year followup study. Clin Orthop Relat Res 175-178, 1999.
7. Bauer KA, Hawkins DW, Peters PC: Fondaparinux, a synthetic pentasaccharide: The first in a new class of antithrombotic agents-the selective factor Xa inhibitors. Cardiovasc Drug Rev 20:37-52, 2002.
8. Becker RC, Ansell J: Antithrombotic therapy: An abbreviated reference for clinicians. Arch Intern Med 155:149-161, 1995.
9. Binns M, Pho R: Femoral vein occlusion during hip arthroplasty. Clinical Orthop Relat Res 255:168-172, 1990.
10. Brotman DJ, Segal JB, Jani JT, Petty BG, Kickler TS: Limitations of d-dimer testing in unselected inpatients with suspected venous thromboembolism. Am J Med 114:276-282, 2003.
11. Catella-Lawson F: Vascular biology of thrombosis: Platelet-vessel wall interactions and aspirin effects. Neurology 57:S5-S7, 2001.
12. Ciccone Jr WJ, Fox PS, Neumyer M, et al: Ultrasound surveillance for asymptomatic deep venous thrombosis after total joint replacement. J Bone Joint Surg 80A:1167-1174, 1998.
13. Ciccone Jr WJ, Reid JS, Pellegrini Jr VD: The role of ultrasonography in thromboembolic disease management in the orthopaedic patient. Iowa Orthop J 19:18-25, 1999.
14. Clagett GP, Anderson Jr FA, Geerts WH, Heit J, Knudson M: Prevention of venous thromboembolism. Chest 114:531S-560S, 1998.
15. Clagett GP, Anderson FAJ, Levine MN, Salzman EW, Wheeler HB: Prevention of venous thromboembolism. Chest 102(Suppl):S391-S407, 1992.
16. Colwell CW, Berkowitz SD, Davidson BL, et al: Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement: A randomized, double-blind study. J Thromb Haemost 1:2119-2130, 2003.
17. Colwell CW, Collins DK, Paulson R, et al: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: Evaluation during hospitalization and three months after discharge. J Bone Joint Surg 81A:932-940, 1999.
18. Colwell CW, Spiro TE, Trowbridge A: Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement surgery. J Bone Joint Surg 76:3-14, 1994.
19. Coventry MB, Noland DR, Beckenbaugh RD: Delayed' prophylactic anticoagulation: A study of results and complications in 2012 total hip arthroplasties. J Bone Joint Surg 55A:1487-1492, 1973.
20. Dahl OE, Andreassen G, Aspelin T, et al: Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (fragmin). Thromb Haemost 77:26-31, 1997.
21. Eikelboom JW, Quinlan DJ, Douketis JD: Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis of the randomised trials. Lancet 358:9-15, 2001.
22. Ericksson BI, Bauer KA, Lassen MR: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip fracture surgery. N Engl J Med 345:1298-1304, 2001.
23. Feeley BT, Lieberman JR: Warfarin prophylaxis following total hip and knee arthroplasty. Tech Orthop 19:266-274, 2004.
24. Fisher CG, Blachut PA, Salvian AJ, Meek RN: Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: A prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma 9:1-7, 1995.
25. Fordyce MJF, Ling RSM: A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg 74B:45-49, 1992.
26. Francis CW, Pellegrini Jr VD, Marder VJ, et al: Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 267:2911-2915, 1992.
27. Francis CW, Pellegrini Jr VD, Totterman S, et al: Prevention of deep-vein thrombosis after total hip arthroplasty: Comparison of warfarin and dalteparin. J Bone Joint Surg 79A:1365-1372, 1997.
28. Francis CW, Pellegrini Jr VD, Totterman S, et al: Prevention of deep-vein thrombosis after total hip arthroplasty: Comparison of warfarin and dalteparin. J Bone Joint Surg 79A:1365-1372, 1997.
29. Freedman KB, Brookenthal KR, Fitzgerald Jr RH, Williams S: A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg 82A:929-938, 2000.
30. Ganz SB, Wilson Jr PD, Cioppa-Mosca J, Peterson MG: The day of discharge after total hip arthroplasty and the achievement of rehabilitation functional milestones: 11-year trends. J Arthroplasty 18:453-457, 2003.
31. Gardner AMN, Fox RH: The venous foot pump: Influence on tissue perfusion and prevention of venous thrombosis. Ann Rheum Dis 51:1173-1178, 1992.
32. Garino JP, Lotke PA, Kitziger KJ, Steinberg ME: Deep venous thrombosis after total joint arthroplasty: The role of compression ultrasonography and the importance of the experience of the technician. J Bone Joint Surg 78A:1359-1365, 1996.
33. Geerts WH, Heit JA, Clagett GP, et al: Prevention of venous thromboembolism. Chest 119:132S-175S, 2001.
34. Geerts WH, Pineo G, Heit J, Bergqvist A, Lassen MR: Prevention of venous thromboembolism. Chest 126:338S-400S, 2004.
35. Ginsberg JS, Caco CC, Brill-Edwards P, et al: Venous thrombosis in patients who have undergone major hip or knee surgery: Detection with compression us and impedance plethysmography. Radiology 181:651-654, 1991.
36. Group TRHA: Rd heparin compared with warfarin for prevention of venous thromboembolism disease following total hip or knee arthroplasty. J Bone Joint Surg 76A:1174-1185, 1994.
37. Haake DA, Berkman SA: Venous thromboembolic disease after hip surgery: Risk factors, prophylaxis, and diagnosis. Orthopedics 242:212-231, 1989.
38. Hamulyak K, Lensing AW, van der Meer J, et al: Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine oral anticoagulant study group. Thromb Haemost 74:1428-1431, 1995.
39. Hartman JT, Pugh JL, Smith RD, et al: Cyclic sequential compression of the lower limb in prevention of deep venous thrombosis. J Bone Joint Surg 64A:1059-1062, 1982.
40. Heijboer H, Buller HR, Lensing AW, et al: A comparison of realtime compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 329:1365-1369, 1993.
41. Heit JA EC: Trowbridge AA, Morrey BF, Gent M, Hirsh J: Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 132:853-861, 2000.
42. Hirsh J, Dalen JE, Deykin D: Oral anticoagulants: Mechanisms of action, clinical effectiveness, and optimal therapeutic range. Chest 102(Suppl):S312-S326, 1992.
43. Hirsh J, Dalen JE, Deykin D, Poller L: Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 102(Suppl):S337-S351, 1992.
44. Hirsh J, Dalen JE, Deykin D, Poller L: Oral anticoagulants: Mechanisms of action, clinical effectiveness, and optimal therapeutic range. Chest 102(Suppl):S312-S326, 1992.
45. Hirsh J, Levine MN: Low molecular weight heparin. Blood 79:1-17, 1992.
46. Hooker JA, Lachiewicz PF, Kelley SS: Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg 81A:690-696, 1999.
47. Horlocker TT, Wedel DJ: Spinal and epidural blockade and perioperative low molecular weight heparin: Smooth sailing on the titanic. Anesth Analg 86:1153-1156, 1998.
48. Horlocker TTWD, Benzon H, Brown DL, et al: Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med 28:172-197, 2003.
49. Hull RD, Pineo G, Francis CW, Bergqvist A: Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery versus warfarin in hip arthroplasty patients: A double-blind, randomized comparison. The North American fragmin trial investigators. Arch Intern Med 160:2199-2207, 2000.
50. Hull RD, Pineo G, Francis CW, et al: Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital versus in-hospital warfarin/out-of-hospital placebo hip arthroplasty patients: A double-blind, randomized comparison. North American fragmin trial investigators. Arch Intern Med 160:2208-2215, 2000.
51. Hull RD, Raskob GE, Pineo G, et al: A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 329:1370-1376, 1993.
52. Hull RD, Raskob GE, Pineo GF, et al: Subcutaneous low-molecular-weight heparin versus warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation: An economic perspective. Arch Intern Med 157:298-303, 1997.
53. Imperiale TF, Speroff T: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 271:1780-1785, 1994.
54. Kaempffe FA, Lifeso RM, Meinking C: Intermittent pneumatic compression versus Coumadin: Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop Relat Res 269:89-97, 1991.
55. Kalodiki E, Hoppensteadt D, Nicolaides AN, et al: Deep venous thrombosis prophylaxis with low-molecular-weight heparin and elastic compression in patients having total hip replacement: A randomised controlled trial. Int Angiol 15:162-168, 1996.
56. Kessler C, Hirsh DR, Jacobs H, MacDougall R: Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolysis 7:437-446, 1996.
57. Koch A, Ziegler S, Breitschwerdt H: Low molecular weight heparin and unfractionated heparin in thrombus prophylaxis: A meta analysis based on original patient data. Thromb Res 102:295-309, 2001.
58. Lassen MR, Bauer KA, Ericksson BI: Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism in elective hip replacement surgery: A randomised double-blind trial. Lancet 359:1715-1720, 2002.
59. Lassen MR, Borris LC, Christiansen HM, et al: Prevention of thromboembolism in 190 hip arthroplasties: Comparison of low-molecular-weight heparin and placebo. Acta Orthop Scand 62:33-38, 1991.
60. Leclerc JR, Gent M, Hirsh DR: The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. Ann Intern Med 127:439-445, 1998.
61. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boiseel JP: Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 305:913-920, 1992.
62. Levine MN, Hirsh J, Landefeld CS: Hemorrhagic complications of anticoagulation treatment. Chest 102(Suppl):S352-S363, 1992.
63. Lieberman JR, Hsu WK: Prevention of venous thromboembolism after total hip and knee arthroplasty. J Bone Joint Surg 87A:2097-2112, 2005.
64. Lieberman JR, Geerts WH: Prevention of venous thromboembolism after total hip and knee arthroplasty. J Bone Joint Surg 76A:1239-1250, 1994.
65. Lieberman JR, Huo MM, Hanway J, et al: The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg 76A:341-348, 1994.
66. Lieberman JR, Sung R, Dorey F, et al: Low-dose warfarin prophylaxis to prevent symptomatic pulmonary embolism after total knee arthroplasty. J Arthroplasty 12:180-184, 1998.
67. Lieberman JR, Wollaeger J, Dorey F, et al: The efficacy of low dose warfarin prophylaxis in preventing pulmonary embolism following total hip arthroplasty. J Bone Joint Surg 79A:319-325, 1997.
68. Lindahl TL, Lundahl TH, Nilsson L: APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee: A prospective study. Thromb Haemost 81:18-21, 1999.
69. Mahomed NN, Barrett JA, Katz JN, et al: Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg 85A:27-32, 2003.
70. Maynard MJ, Sculco TP, Ghelman B: Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop Relat Res 273:125-130, 1991.
71. Meyerowitz B, Nelson R: Measurement of the velocity of blood in lower limb veins with and without compression. Surgery 56:481-486, 1964.
72. Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM: Prophylactic agents for venous thrombosis in elective hip surgery: Meta-analysis of studies using venographic assessment. Arch Intern Med 153:2221-2228, 1983.
73. Mont MA, Jones LC, Rajadhyaksha AD, et al: Risk factors for pulmonary emboli after total hip or knee arthroplasty. Clin Orthop Relat Res 422:154-163, 2004.
74. Nurmohamed MT, Rosendaal FR, Buller HR, et al: Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis. Lancet 340:152-156, 1992.
75. Paiement G, Wessinger SJ, Waltman AC, Harris WH: Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty 2:23-26, 1987.
76. Planes A, Vochelle N, Darmon JY, et al: Efficacy and safety of post-discharge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement: A prospective randomised double-blind placebo-controlled trial. Drugs 52(Suppl 7):47-54, 1996.
77. Planes A, Vochelle N, Darmon JY, et al: Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo. Lancet 348:224-228, 1996.
78. Planes A, Vochelle N, Fafola M: Venous thromboembolic prophylaxis in orthopedic surgery: Knee surgery. Semin Thromb Hemost 25(Suppl 3):73-77, 1999.
79. Planes A, Vochelle N, Fagola M: Total hip replacement and deep vein thrombosis: A venographic and necropsy study. J Bone Joint Surg 72B:9-13, 1990.
80. Pradoni P, Bruchi O, Sabbion P: Prolonged thromboprophylaxis with oral anticoagulation after total hip arthroplasty. Arch Intern Med 162:1966-1971, 2002.
81. Robinson KS, Anderson DR, Gross M, et al: Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: The post-arthroplasty screening study: A randomized, controlled trial. Ann Intern Med 127:439-445, 1997.
82. Ryan MGWG, Potter HG, Sharrock N, et al: Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg 84A:1998-2004, 2002.
83. Salvati EA, Pellegrini Jr VD, Sharrock N, Lotke PA, Murray DW: Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg 82A:252-270, 2000.
84. Santori FS, Vitullo A, Stopponi M, Santori N, Ghera S: Prophylaxis against deep-vein thrombosis in total hip replacement: Comparison of heparin and foot impulse pump. J Bone Joint Surg 76B:579-583, 1994.
85. Sculco TP, Colwell CW, Pellegrini Jr VD, Westrich G, Bottner F: Prophylaxis against venous thromboembolic disease in patients having a total hip or knee arthroplasty. J Bone Joint Surg 84A:466-477, 2002.
86. Sharrock NE, Go G, Harpel PC, et al: The John Charnley Award. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res 319:16-27, 1995.
87. Trial P: Prevention of pulmonary embolism and deep venous thrombosis with low-dose aspirin: Pulmonary embolism prevention (pep) trial. Lancet 355:1295-1302, 2000.
88. Trowbridge A, Boese CK, Woodruff B, et al: Incidence of post-hospitalization proximal deep venous thrombosis after total hip arthroplasty. Clin Orthop Relat Res 299:203-208, 1994.
89. Turpie AG, Bauer KA, Ericksson BI: Fondaparinux versus enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery: A meta-analysis of 4 randomised studies. Arch Intern Med 162:1833-1840, 2002.
90. Turpie AG, Bauer KA, Ericksson BI: Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip replacement surgery: A randomised double-blind trial. Lancet 359:1721-1729, 2002.
91. Turpie AG, Bengt I, Ericksson BI, Bauer KA: Fondaparinux. J Am Acad Orthop Surg 12:371-375, 2004.
92. Vanhoutte PM, Boulanger CM, Mombouli JV: Endothelium derived relaxing factors and converting enzyme inhibition. Am J Cardiol 76:3E-12E, 1995.
93. Vresilovic Jr EJ, Hozack WJ, Booth RE, Rothman RH: Incidence of pulmonary embolism after total knee arthroplasty with low-dose Coumadin prophylaxis. Clin Orthop Relat Res 286:27-31, 1993.
94. Wahlander K, Larson G, Lindahl TL, et al: Factor V Leiden (g1691a) and prothrombin gene g20210a mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 87:580-585, 2002.
95. Warwick D, Bannister GC, Glew D, et al: Perioperative low-molecular-weight heparin: Is it effective and safe? J Bone Joint Surg 77B:715-719, 1995.
96. Warwick D, Harrison J, Glew D, et al: Comparison of the use of a foot pump with the use of low-molecular weight heparin for the prevention of deep-vein thrombosis after total hip replacement. J Bone Joint Surg 80A:1158-1166, 1998.
97. Warwick D, Whitehouse S: Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg 79B:780-786, 1997.
98. Westrich GH, Sculco TP: Prophylaxis against deep venous thrombosis after total knee arthroplasty: Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg 78A:826-834, 1996.
99. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA: Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: An analysis of genetic factors. J Bone Joint Surg 84A:2161-2167, 2002.
100. White RH, Henderson MC: Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med 8:365-371, 2002.
101. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W: Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 158:1525-1531, 1998.
102. Woolson ST, Zehnder JL, Maloney WJ: Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty. J Arthroplasty 13:207-210, 1999.